FIELD: chemistry.
SUBSTANCE: molecule of nucleic acid is proposed for expressing HPV 52 L1 protein in yeast cells, as well as a vector which contains this molecule, yeast host cell which contains the vector and a method of producing particles similar to the HPV 52 virus.
EFFECT: invention can be used for making vaccines and providing for effective papillomavirus infection immunoprophylaxis.
8 cl, 5 dwg, 7 ex
Title | Year | Author | Number |
---|---|---|---|
OPTIMISED EXPRESSION OF HPV 58 L1 IN YEAST | 2004 |
|
RU2370538C2 |
NUCLEIC ACID MOLECULE ENCODING HPV 31 L1, EXPRESSION VECTOR, HOST CELL, VIRUS-LIKE PARTICLE AND METHOD OF ITS OBTAINMENT, VACCINE, PHARMACEUTICAL COMPOSITION AND METHODS INVOLVING THEM | 2004 |
|
RU2356943C2 |
OPTIMISED EXPRESSION LI HPV45 IN YEAST | 2004 |
|
RU2360001C2 |
VACCINE COMPOSITION APPLICABLE IN HPV AND HEPATITIS VIRUS INFECTIONS, AND METHOD FOR PREPARING IT | 2009 |
|
RU2509570C2 |
PAPILLOMA VIRAL VACCINES | 1995 |
|
RU2206608C2 |
RECOMBINANT VACCINE FOR PREVENTION OF HUMAN PAPILLOMAVIRUS INFECTION AND METHOD OF ITS PREPARATION | 2014 |
|
RU2546243C1 |
METHOD OF OBTAINING A RECOMBINANT VACCINE FOR PREVENTION OF HUMANPAPILLOMA VIRUS INFECTION, RECOMBINANT VACCINE | 2018 |
|
RU2681174C1 |
HPV CHIMERIC PARTICLE | 2012 |
|
RU2642287C2 |
PAPILLOMA VIRUS PURIFIED PROTEINS | 1995 |
|
RU2161651C2 |
RECOMBINANT STRAIN OF YEAST Hansenula polymorpha - PRODUCER OF MAJOR CAPSID PROTEIN L1 OF HUMAN PAPILLOMAVIRUS OF TYPE 56 | 2014 |
|
RU2546240C1 |
Authors
Dates
2009-11-20—Published
2005-03-18—Filed